Overview

Allergy Diagnostics Market is poised to register a CAGR of 11.1% during the forecast period 2022 to 2028.   

The ever-rising environmental pollution levels, increase in the number of patients prone to allergens is anticipated to drive the market growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Allergy Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Allergy Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Allergy Diagnostics Market:

• Thermo Fisher Scientific Inc.
• Siemens Ag
• Danaher Corporation
• Omega Diagnostics Group Plc
• Hitachi Chemical Co.,Ltd.
• Biomérieux Sa
• Stallergenes Greer
• Hob Biotech Group Suzhou Co.,Ltd.
• Hycor Biomedical,Inc.
• Lincoln Diagnostics,Inc.
• R-Biopharm Ag

(Note: The list of the major players will be updated with the latest market scenario and trends)

Allergy Diagnostics Market Segmentation:

By Product and Service

• Assay Kits
• Instruments
  o Immunoassay Analyzers
  o Luminometers
  o ELISA Analyzers
  o Other Instruments
• Services

By Test Type

• In Vivo Tests
• In Vitro Tests

By Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

By End User

• Diagnostics Laboratories
• Hospital-based Laboratories
• Academic and Research Institutes
• Other End Users

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
​​​​​​​• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Allergy Diagnostics Market By Product and Service, By Test Type, By Allergen, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 
 2.  Research Methodology 
       2.1 Research Data 
              2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
              2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  
3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights
4. Allergy Diagnostics Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Market Overview
       5.1. Market Dynamics
               5.1.1. Market Driver Analysis
                          5.1.1.1. Increasing focus of Allergy Diagnostics Companies on Brand Protection
                          5.1.1.2. Untapped Opportunities in Emerging Regions
               5.1.2. Market Restraint Analysis
                           5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
               5.1.3. Industry Challenges
                           5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Allergy Diagnostics Market Analysis Tools
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies
7. Allergy Diagnostics Market, By Product and Service Historical Analysis and Forecast 2022-2028 (USD Million)
       7.1. Assay Kits
       7.2. Instruments
               7.2.1. Immunoassay Analyzers
               7.2.2. Luminometers
               7.2.3. ELISA Analyzers
               7.2.4. Other Instruments
       7.3. Services          
8. Allergy Diagnostics Market, By Test Type Historical Analysis and Forecast 2022-2028 (USD Million)
       8.1. In Vivo Tests
       8.2. In Vitro Tests 
9. Allergy Diagnostics Market, By Allergen Historical Analysis and Forecast 2022-2028 (USD Million)
       9.1. Inhaled Allergens
       9.2. Food Allergens
       9.3. Drug Allergens
       9.4. Other Allergens
10. Allergy Diagnostics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
       10.1. Diagnostics Laboratories
       10.2. Hospital-based Laboratories
       10.3. Academic and Research Institutes
       10.4. Other End Users  
11.  North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       11.1. Introduction
       11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            11.2.1. U.S.A
            11.2.2. Canada
            11.2.3. Mexico
       11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       12.1. Introduction
       12.2. Regional Market Trends
       12.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            12.3.1. Brazil
            12.3.2. Venezuela
            12.3.3. Argentina
            12.3.4. Rest of Latin America
       12.4. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            13.2.1. Germany
            13.2.2. U.K
            13.2.3. France
            13.2.4. Italy
            13.2.5. Spain
            13.2.6. Russia
            13.2.7. Poland
            13.2.8. Switzerland
            13.2.9. Rest of Western Europe
14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       14.1. Introduction
       14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             14.2.1. Japan
             14.2.2. China
             14.2.3. Singapore
             14.2.4. India
             14.2.5. Australia and New Zealand
             14.2.6. ASEAN
             14.2.7. South Korea
             14.2.8. Rest of Asia Pacific
       14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       15.1. Introduction
       15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             15.2.1. GCC
             15.2.2. Israel
             15.2.3. South Africa
             15.2.4. Rest of MEA
       15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape   
       16.1. Global Landscape - Key Players, Revenue and Presence
       16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
       16.3. Global Emerging Companies
       16.4. North America - Market Share Analysis and Key Regional Players
       16.5. Europe - Market Share Analysis and Key Regional Players
       16.6. Asia Pacific - Market Share Analysis and Key Regional Players
       16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       17.1. Thermo Fisher Scientific Inc.
                17.1.1. Company Overview
                17.1.2. Product Portfolio
                17.1.3. SWOT Analysis
                17.1.4. Financial Overview
                17.1.5. Strategic Overview
       17.2. Siemens Ag
                17.2.1. Company Overview
                17.2.2. Product Portfolio
                17.2.3. SWOT Analysis
                17.2.4. Financial Overview
                17.2.5. Strategic Overview
       17.3. Danaher Corporation
                17.3.1. Company Overview
                17.3.2. Product Portfolio
                17.3.3. SWOT Analysis
                17.3.4. Financial Overview
                17.3.5. Strategic Overview
       17.4. Omega Diagnostics Group Plc
                17.4.1. Company Overview
                17.4.2. Product Portfolio
                17.4.3. SWOT Analysis
                17.4.4. Financial Overview
                17.4.5. Strategic Overview
       17.5. Hitachi Chemical Co.,Ltd.
                17.5.1. Company Overview
                17.5.2. Product Portfolio
                17.5.3. SWOT Analysis
                17.5.4. Financial Overview
                17.5.5. Strategic Overview
       17.6. Biomérieux Sa
                17.6.1. Company Overview
                17.6.2. Product Portfolio
                17.6.3. SWOT Analysis
                17.6.4. Financial Overview
                17.6.5. Strategic Overview
       17.7. Stallergenes Greer
                17.7.1. Company Overview
                17.7.2. Product Portfolio
                17.7.3. SWOT Analysis
                17.7.4. Financial Overview
                17.7.5. Strategic Overview
       17.8. Hob Biotech Group Suzhou Co.,Ltd.
                17.8.1. Company Overview
                17.8.2. Product Portfolio
                17.8.3. SWOT Analysis
                17.8.4. Financial Overview
                17.8.5. Strategic Overview
       17.9. Hycor Biomedical,Inc.
                17.9.1. Company Overview
                17.9.2. Product Portfolio
                17.9.3. SWOT Analysis
                17.9.4. Financial Overview
                17.9.5. Strategic Overview
       17.10. Lincoln Diagnostics,Inc.
                17.10.1. Company Overview
                17.10.2. Product Portfolio
                17.10.3. SWOT Analysis
                17.10.4. Financial Overview
                17.10.5. Strategic Overview
       17.11. R-Biopharm Ag
                17.11.1. Company Overview
                17.11.2. Product Portfolio
                17.11.3. SWOT Analysis
                17.11.4. Financial Overview
                17.11.5. Strategic Overview
18. Pre and Post COVID-19 Impact
       18.1. Positive influence on the healthcare industry
       18.2. The financial disruption of the manufacturing sector
       18.3. Impact of COVID-19 on emerging companies
       18.4. Significant mandates in the healthcare regulations initiated by administrations
       18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Tables

Figures